SurvivorNet on MSN
A new type of immunotherapy drug showed striking results in hard-to-treat lung cancer, but more data is needed for US patients
A large clinical trial in China (HARMONi-6) found that a new immunotherapy drug, ivonescimab, may help patients with advanced ...
Drugmakers including BioNTech, Merck & Co. and Pfizer are all testing their investigational PD-1/VEGF bispecifics against ...
CHICOPEE, Mass. (WWLP) – World Lung Cancer Day has been observed every year on August 1 since 2012 to raise awareness about the risk of the disease. Cooler start to August in western Massachusetts The ...
A study by the University of Barcelona has discovered why the two main types of lung cancer—adenocarcinoma of the lung and ...
Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...
Metastatic progression reduction is associated with GLP-1 RA initiation after cancer diagnosis across multiple solid tumors.
‘Wonder pill’ found to reduce tumours by 30% in six cancer types - The drug makes tumours visible to the immune system and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results